Shares in Black Diamond Therapeutics rose after the company outlined positive initial data from Phase 2 trials of BDTX-1535, an oral cancer treatment. Shares were up 46% in premarket trading at $6.94.

Robert Burns, an analyst from H.C. Wainwright, reiterated the Buy rating on Black Diamond Therapeutics (BDTX – Research Report). The ...

This award-winning Scottish band are back! Their live show features fyrebrand sonic sermons, stunning original compositions, old time blues and work songs. Once the coals get hot, these gents are ...

The former president has sold branded sneakers, Bibles, NFTs, and coffee table books. Now he’s moving into timepieces ...

Grand Teton National Park rejected permits for photographers who documented Michelino Sunseri’s Labor Day attempt to set a ...

Trump unveils "Official Trump Watch Collection" with prices ranging from $499 to $100,000 for diamond-encrusted models. The ...

Sneakerheads and sports fans, get ready for a major blast from the past! The iconic Nike Air Diamond Turf is making a ...

Additionally, Nike’s CEO has decided to step down after a decline in sales under his leadership at the company. French label ...

A nonprofit organization, Passavant Memorial Homes Family of Services raised more than $143,000 for individuals with ...

Arriving in the iconic backpack-shaped bottle, the new scent stays true to MCM’s signature fragrance line, encased in its trademark Visetos pattern. Across both the bottle and packaging, black and ...

Since that time it’s come down somewhat significantly in price, and can be picked up from Philips' official site in black, white or pink colourways for £169.99 / $238. The DiamondClean 9000 ...